The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer

Cancer Research

Volumn 72, Issue 16, 2012, Pages 4028-4036

  Jönsson, Göran ^a   Staaf, Johan ^a   Vallon Christersson, Johan ^a   Ringneŕ, Markus ^a   Gruvberger Saal, Sofia K ^a   Saal, Lao H ^a   Holm, Karolina ^a   Hegardt, Cecilia ^a   Arason, Adalgeir ^c,d   Fagerholm, Rainer ^e   Persson, Camilla ^a   Grabau, Dorthe ^a   Johnsson, Ellinor ^a   Lov̈gren, Kristina ^a   Magnusson, Linda ^a   Heikkilä, Päivi ^e   Agnarsson, Bjarni A ^c,d   Johannsson, Oskar T ^c   Malmstrom̈, Per ^a,b   Fernö, Mårten ^a   Olsson, Håkan ^a   Loman, Niklas ^a,b   Nevanlinna, Heli ^e   Barkardottir, Rosa B ^c,d   Borg, Åke ^a   more..

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d UNIVERSITY OF ICELAND   (Iceland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BRCA1 DEFICIENT BASAL LIKE BREAST CANCER; BREAST CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FAMILIAL CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METHYLATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TP53 GENE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BRCA1 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENE REARRANGEMENT; GENES, BRCA1; GENES, RETINOBLASTOMA; GERM-LINE MUTATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS, BASAL CELL; RETINOBLASTOMA PROTEIN; TRANSCRIPTOME;

EID: 84865146340     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-0097     Document Type: Article

References (25)

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature 2000;406: 747-52.
2. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003;100: 8418-23. (Pubitemid 36842560)
3. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol 2009;27:1160-7.
4. Jonsson G, Staaf J, Vallon-Christersson J, Ringnér M, Holm K, Hegardt C, et al. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics. Breast Cancer Res 2010;12:R42.
5. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006;10:529-41. (Pubitemid 44854748)
6. Russnes HG, Vollan HK, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, et al. Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med 2010; 2:38ra47.
7. Prat A, Perou CM. Deconstructing the molecular portraits of breast cancer. Mol Oncol 2011;5:5-23.
8. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L, et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 2002;20:2310-8. (Pubitemid 34441658)
9. Loman N, Johannsson O, Bendahl PO, Borg A, Ferno M, Olsson H. Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer 1998;83:310-9. (Pubitemid 28317811)
10. Jonsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, et al. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 2005;65:7612-21. (Pubitemid 41297233)
11. Herschkowitz JI, He X, Fan C, Perou CM. The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas. Breast Cancer Res 2008; 10:R75.
12. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, Liu JC, et al. Rb deletion in mouse mammary progenitors induces luminal-B or basallike/ EMT tumor subtypes depending on p53 status. J Clin Invest 2010;120:3296-309.
13. Saal LH, Gruvberger-Saal SK, Persson C, Lövgren K, Jumppanen M, Staaf J, et al. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 2008;40: 102-7.
14. Johannsson OT, Staff S, Vallon-Christersson J, Kytöla S, Gudjonsson T, Rennstam K, et al. Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier. Lab Invest 2003;83:387-96. (Pubitemid 36351000)
15. Jonsson G, Staaf J, Olsson E, Heidenblad M, Vallon-Christersson J, Osoegawa K, et al. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization. Genes Chromosomes Cancer 2007;46:543-58. (Pubitemid 46649569)
16. Ringner M, Fredlund E, Hakkinen J, Borg A, Staaf J. GOBO: Gene Expression-Based Outcome for Breast Cancer Online. PLoS One 2011;6:e17911.
17. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A 2007;104:20007-12.
18. Staaf J, Torngren T, Rambech E, Johansson U, Persson C, Sellberg G, et al. Detection and precise mapping of germline rearrangements in BRCA1, BRCA2, MSH2, and MLH1 using zoom-in array comparative genomic hybridization (aCGH). Hum Mutat 2008;29:555-64. (Pubitemid 351536995)
19. Venkatraman ES, Olshen AB. A faster circular binary segmentation algorithm for the analysis of array CGH data. Bioinformatics 2007;23: 657-63. (Pubitemid 46554715)
20. Dahlen A, Debiec-Rychter M, Pedeutour F, Domanski HA, Höglund M, Bauer HC, et al. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 2003; 103:616-23. (Pubitemid 36091464)
21. Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R, et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 1997;57:1222-7. (Pubitemid 27152540)
22. Johannsson OT, Idvall I, Anderson C, Borg A, Barkardóttir RB, Egilsson V, et al. Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer 1997;33:362-71.
23. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48. (Pubitemid 32167867)
24. Ravasi T, Suzuki H, Cannistraci CV, Katayama S, Bajic VB, Tan K, et al. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 2010;140:744-52.
25. Ciriello G, Cerami EG, Sander C, Schultz N. Mutual exclusivity analysis identifies oncogenic network modules. Genome Res 2012;22: 398-406.